Michael Izard
Clinical Associate Professor
Radiation Oncology
Northern Cancer Institute
Australia
Biography
Clinical Associate Professor Michael Izard began his medical career at The Middlesex Hospital in London. Moving to Australia he completed training in radiation oncology at Sydney’s St Vincent’s and Westmead Hospitals in 1993, with further Fellowship training at The Princess Margaret Hospital, Toronto, Canada. Dr Izard consults at different Sydney hospitals, attending their MDTs, and is actively involved in teaching at undergraduate and post-graduate level. He is an invited and Founder member to the NSW Board of the Prostate Cancer Foundation of Australia, and is a ministerial appointee of the Specialist Medical Review Council of the Department of Veterans Affairs. He is the lead Radiation Oncologist for the Gamma Knife unit at Macquarie University Hospital and argues for aggressive treatment of intracranial metastases. He has been published in international journals, including his prostate brachytherapy results.
Research Interest
His specialities include prostate cancer and breast cancer, but he has a particular interest in brachytherapy and stereotactic radiotherapy (known also as SBRT or SABR when used in the body and SRS when used in the brain).
Publications
-
Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.
-
Does prostate-specific antigen nadir predict longer-term outcomes of prostate cancer after neoadjuvant and adjuvant androgen deprivation therapy in conjunction with brachytherapy?
-
Schwannoma showing avid uptake on 68Ga-PSMA-HBED-CC PET/CT.
